The matched-control analysis showed a trend toward a better response to chemotherapy for patients with DLBCL than T/HRBCL, whereas no difference was observed in OS between the two groups[ 11 ].
← all excerpts
Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
1
—
—